The treatment of chronic disease often requires repeated and prolonged access to the vascular system. As it is impractical and dangerous to insert and remove a catheter at every session, patients are often fitted with a semi-permanent catheter which is left in place for months or years.
A valve may be used to seal the proximal end of such a semi-permanently implanted device when the device is not in use. One common type of valve is the Pressure Actuated Safety Valve (PASV), which open when a fluid pressure in the catheter exceeds a preselected threshold level. These PASV's often include a slitted membrane designed to remain closed when subject to pressures applied by the vascular system or through normal movement of the patient and to open when fluid pressure applied thereto to introduce fluids to or remove fluids from the vascular system.
In one aspect, the present invention is directed to a valve assembly for a catheter comprising a housing having a lumen extending therethrough a first port opening to a proximal end of the lumen via a first port passage and a valve disposed in the first port passage, the valve being biased toward a closed configuration to prevent fluid flow therethrough when the first port passage is not in use in combination with a second port opening of the housing in fluid connection with a proximal end of the lumen via a second port passage, the second port passage opening to the lumen distally of the safety valve.
The present invention may be further understood with reference to the following description and the appended drawings, wherein like elements are referred to with the same reference numerals. The invention relates to devices for connecting a source of pressurized fluid to a valved catheter, without damaging the valve of the catheter. More specifically, the invention relates to a valve housing and connector for a semi-permanently implanted catheter bypassing the catheter's safety valve to avoid damage which might otherwise occur through the introduction of fluid at a high flow rate and/or pressure.
The proximal ends of semi-permanently implanted catheters generally extend out of the body and often include provisions for connection to external medical devices. For example, a semi-permanently implanted catheter may include a connector including a flow control valve which, as described above, seals the catheter when not in use and permits fluid flow therethrough when fluid transfer to and/or from the vascular system is desired. The flow control valve housing and/or the connector may be formed as a single component or may be separate from one another with either or both components coupled to the catheter or unitarily formed therewith.
Therapeutic procedures infusing fluids such as chemotherapy agents, drugs and blood products often use slower flow rates and lower injection pressures. Typically, a 10 cc syringe is the smallest that should be used and injection pressure is generally maintained less than 1 psi although pressures up to 40 psi are recommended for certain infusion pumps. However, in certain procedures fluids are administered at higher pressures and/or flow rates. For example, contrast media used in the visualization of blood vessels and structures within the body may require power injections at higher pressures and flow rates. For this reason, more robust catheters are often used for such power injection procedures—e.g., up to and over 5 cc/min.
The exemplary embodiments of the present invention allow catheters suitable for long term implantation to be used for low pressure applications as well as higher pressure applications obviating the need to insert a separate catheter for higher pressure applications. In particular, a valve housing and connector portion of a valved catheter according to the invention are designed for low pressure infusion of fluids to and withdrawal of fluids from the vascular system as well as for the power injection of fluids. The exemplary device is designed prevents damage to the safety valve that might otherwise result from a power injection through the catheter.
The infusion port 110 of the exemplary embodiment is fluidly connected to a lumen 124 of the catheter 104 via a first passage 114 with a valve 120 controlling the flow of fluid though the first passage 114. The valve 120 prevents the leakage of fluids from the catheter 104 and the introduction of contaminants into the body via the catheter 104 and also minimizes incidences of catheter occlusion while eliminating the need for a catheter clamp or cap. For example, the valve 120 may be a pressure actuated safety valve (PASV) that comprises a slitted membrane 122 sealing the first passage 114 when the valve assembly 100 is not in use.
The slitted membrane 122 is biased to the closed configuration by, for example, tension of the elastic material from which it is manufactured. When a fluid flowing through the first passage 114 applies to the valve 120 a pressure above a predetermined threshold level, the bias of the slitted membrane 122 is overcome and the slit opens allowing fluids to pass through the valve 120. As described above, the valve 120 is preferably designed so that this threshold pressure exceeds pressures which will be applied to the valve 120 by normal anatomical activity and motions of the patient.
The valve assembly 100 also comprises a power injection port 112 designed to connect with a medical device for supplying fluid at pressures and/or flow rates exceeding levels safe for the valve 120. The power injection port 112 is in fluid communication with the lumen 124 of the catheter 104 via a second flow passage 116. In the exemplary embodiment, the second flow passage 116 and the first flow passage 114 of the infusion port 110 merge into the lumen 124 at a location downstream from the valve 120. In this manner, fluids introduced into the power injection port 112 through the flow passage 116 bypass the valve 120. Thus fluids power injected into the catheter 104 do not pass through and damage the valve 120 and the valve 120 does not limit the pressure and/or flow rates at which fluids may be injected through the valve assembly 100 and the catheter 104.
According to the exemplary embodiment shown in
As shown in
As shown in
As described above, a lumen selector 250 of the valve assembly 202 prevents high pressure fluids introduced through the power injection access site 212 from applying excessive back pressure to the distal face 223 of the slitted membrane 222. For example, the lumen selector 250 may comprise a partition 252 movable about a pivot point 254 through an angle α between positions A and B of
As shown in
Those skilled in the art will understand that, instead of the lumen selector, a check valve may be installed in the infusion passage permitting flow distally therethrough while preventing backflow at all times. The power injection port may then be sealed by a simple cap.
The present invention has been described with reference to specific embodiments, and more specifically to a connector used alternatively for power injecting a fluid and to infuse a fluid into a valved PICC. However, other embodiments may be devised that are applicable to other medical devices, without departing from the scope of the invention. Accordingly, various modifications and changes may be made to the embodiments, without departing from the broadest spirit and scope of the present invention as set forth in the claims that follow. The specification and drawings are accordingly to be regarded in an illustrative rather than restrictive sense.
Number | Name | Date | Kind |
---|---|---|---|
2446571 | Browne | Mar 1944 | A |
2720881 | Weaver et al. | Oct 1955 | A |
2755060 | Twyman | Jul 1956 | A |
3113586 | Edmark, Jr. | Dec 1963 | A |
3159175 | MacMillan | Dec 1964 | A |
3159176 | Russell et al. | Dec 1964 | A |
3477438 | Allen et al. | Nov 1969 | A |
3514438 | Nelsen et al. | May 1970 | A |
3525357 | Koreski | Aug 1970 | A |
3621557 | Cushman et al. | Nov 1971 | A |
3669323 | Harker et al. | Jun 1972 | A |
3673612 | Merrill et al. | Jul 1972 | A |
3674183 | Venable et al. | Jul 1972 | A |
3710942 | Rosenberg | Jan 1973 | A |
3788327 | Donowitz et al. | Jan 1974 | A |
3811466 | Ohringer | May 1974 | A |
3955594 | Snow | May 1976 | A |
4072146 | Howes | Feb 1978 | A |
4142525 | Binard et al. | Mar 1979 | A |
4143853 | Abramson | Mar 1979 | A |
4244379 | Smith | Jan 1981 | A |
4387879 | Tauschinski | Jun 1983 | A |
4405316 | Mittleman | Sep 1983 | A |
4434810 | Atkinson | Mar 1984 | A |
4447237 | Frisch et al. | May 1984 | A |
4468224 | Enzmann et al. | Aug 1984 | A |
4502502 | Krug | Mar 1985 | A |
4524805 | Hoffman | Jun 1985 | A |
4543087 | Sommercorn et al. | Sep 1985 | A |
4552553 | Schulte et al. | Nov 1985 | A |
4610665 | Matsumoto et al. | Sep 1986 | A |
4616768 | Flier | Oct 1986 | A |
4673393 | Suzuki et al. | Jun 1987 | A |
4681572 | Tokarz et al. | Jul 1987 | A |
4692146 | Hilger | Sep 1987 | A |
4722725 | Sawyer et al. | Feb 1988 | A |
4790832 | Lopez | Dec 1988 | A |
4798594 | Hillstead | Jan 1989 | A |
4801297 | Mueller | Jan 1989 | A |
4908028 | Colon et al. | Mar 1990 | A |
4944726 | Hilal et al. | Jul 1990 | A |
4946448 | Richmond | Aug 1990 | A |
5000745 | Guest et al. | Mar 1991 | A |
5009391 | Steigerwald | Apr 1991 | A |
5030210 | Alchas et al. | Jul 1991 | A |
5084015 | Moriuchi | Jan 1992 | A |
5098405 | Peterson et al. | Mar 1992 | A |
5125893 | Dryden | Jun 1992 | A |
5147332 | Moorehead | Sep 1992 | A |
5149327 | Oshiyama | Sep 1992 | A |
5167638 | Felix et al. | Dec 1992 | A |
5169393 | Moorehead et al. | Dec 1992 | A |
5176652 | Littrell | Jan 1993 | A |
5176662 | Bartholomew et al. | Jan 1993 | A |
5201722 | Moorehead et al. | Apr 1993 | A |
5205834 | Moorehead et al. | Apr 1993 | A |
5249598 | Schmidt | Oct 1993 | A |
5254086 | Palmer et al. | Oct 1993 | A |
5324274 | Martin | Jun 1994 | A |
5330424 | Palmer et al. | Jul 1994 | A |
5336203 | Goldhardt et al. | Aug 1994 | A |
5360407 | Leonard et al. | Nov 1994 | A |
5370624 | Edwards et al. | Dec 1994 | A |
5395352 | Penny | Mar 1995 | A |
5396925 | Poli et al. | Mar 1995 | A |
5399168 | Wadsworth et al. | Mar 1995 | A |
5401255 | Sutherland et al. | Mar 1995 | A |
D357735 | McPhee | Apr 1995 | S |
5405340 | Fageol et al. | Apr 1995 | A |
5411491 | Goldhardt et al. | May 1995 | A |
5453097 | Paradis | Sep 1995 | A |
5454784 | Atkinson et al. | Oct 1995 | A |
5469805 | Gibbs et al. | Nov 1995 | A |
5470305 | Arnett et al. | Nov 1995 | A |
5484420 | Russo | Jan 1996 | A |
5542923 | Ensminger et al. | Aug 1996 | A |
5554136 | Luther | Sep 1996 | A |
5562618 | Cai et al. | Oct 1996 | A |
5571093 | Cruz et al. | Nov 1996 | A |
5575769 | Vaillancourt et al. | Nov 1996 | A |
5624395 | Mikhail et al. | Apr 1997 | A |
5637099 | Durdin et al. | Jun 1997 | A |
5667500 | Palmer et al. | Sep 1997 | A |
5707357 | Mikhail et al. | Jan 1998 | A |
5743873 | Cai et al. | Apr 1998 | A |
5743884 | Hasson et al. | Apr 1998 | A |
5743894 | Swisher | Apr 1998 | A |
5752938 | Flatland et al. | May 1998 | A |
5803078 | Brauner | Sep 1998 | A |
5807349 | Person et al. | Sep 1998 | A |
5810789 | Powers et al. | Sep 1998 | A |
5843044 | Moorehead | Dec 1998 | A |
5853397 | Shemesh et al. | Dec 1998 | A |
5865308 | Qin et al. | Feb 1999 | A |
5944698 | Fischer et al. | Aug 1999 | A |
5984902 | Moorehead | Nov 1999 | A |
6033393 | Balbierz et al. | Mar 2000 | A |
6045734 | Luther et al. | Apr 2000 | A |
6050934 | Mikhail et al. | Apr 2000 | A |
6056717 | Finch et al. | May 2000 | A |
6062244 | Arkans | May 2000 | A |
6092551 | Bennett | Jul 2000 | A |
6099505 | Ryan et al. | Aug 2000 | A |
6120483 | Davey et al. | Sep 2000 | A |
6152909 | Bagaoisan et al. | Nov 2000 | A |
6210366 | Sanfilippo | Apr 2001 | B1 |
6227200 | Crump et al. | May 2001 | B1 |
6270489 | Wise et al. | Aug 2001 | B1 |
6306124 | Jones et al. | Oct 2001 | B1 |
6364861 | Feith et al. | Apr 2002 | B1 |
6364867 | Wise et al. | Apr 2002 | B2 |
6375637 | Campbell et al. | Apr 2002 | B1 |
6436077 | Davey et al. | Aug 2002 | B1 |
6442415 | Bis et al. | Aug 2002 | B1 |
6446671 | Armenia et al. | Sep 2002 | B2 |
6508791 | Guerrero | Jan 2003 | B1 |
6551270 | Bimbo et al. | Apr 2003 | B1 |
6610031 | Chin | Aug 2003 | B1 |
6726063 | Stull et al. | Apr 2004 | B2 |
6786884 | DeCant et al. | Sep 2004 | B1 |
6874999 | Dai et al. | Apr 2005 | B2 |
6953450 | Baldwin et al. | Oct 2005 | B2 |
6994314 | Garnier et al. | Feb 2006 | B2 |
7081106 | Guo et al. | Jul 2006 | B1 |
7252652 | Moorehead et al. | Aug 2007 | B2 |
7291133 | Kindler et al. | Nov 2007 | B1 |
7316655 | Garibotto et al. | Jan 2008 | B2 |
7435236 | Weaver et al. | Oct 2008 | B2 |
7601141 | Dikeman et al. | Oct 2009 | B2 |
7637893 | Christensen et al. | Dec 2009 | B2 |
7758541 | Wallace et al. | Jul 2010 | B2 |
20010023333 | Wisse et al. | Sep 2001 | A1 |
20010037079 | Burbank et al. | Nov 2001 | A1 |
20020010425 | Guo et al. | Jan 2002 | A1 |
20020016584 | Wise et al. | Feb 2002 | A1 |
20020121530 | Socier | Sep 2002 | A1 |
20020156430 | Haarala et al. | Oct 2002 | A1 |
20020165492 | Davey et al. | Nov 2002 | A1 |
20020193752 | Lynn | Dec 2002 | A1 |
20030122095 | Wilson et al. | Jul 2003 | A1 |
20040034324 | Seese et al. | Feb 2004 | A1 |
20040064128 | Raijman et al. | Apr 2004 | A1 |
20040102738 | Dikeman | May 2004 | A1 |
20040108479 | Garnier et al. | Jun 2004 | A1 |
20040186444 | Daly et al. | Sep 2004 | A1 |
20040193119 | Canaud et al. | Sep 2004 | A1 |
20040210194 | Bonnette et al. | Oct 2004 | A1 |
20040267185 | Weaver et al. | Dec 2004 | A1 |
20050010176 | Dikeman et al. | Jan 2005 | A1 |
20050027261 | Weaver et al. | Feb 2005 | A1 |
20050043703 | Nordgren | Feb 2005 | A1 |
20050049555 | Moorehead et al. | Mar 2005 | A1 |
20050149116 | Edwards et al. | Jul 2005 | A1 |
20050171490 | Weaver et al. | Aug 2005 | A1 |
20050171510 | DiCarlo et al. | Aug 2005 | A1 |
20050283122 | Nordgren | Dec 2005 | A1 |
20060129092 | Hanlon et al. | Jun 2006 | A1 |
20060135949 | Rome et al. | Jun 2006 | A1 |
20060149211 | Simpson et al. | Jul 2006 | A1 |
20070161940 | Blanchard et al. | Jul 2007 | A1 |
20070161970 | Spohn et al. | Jul 2007 | A1 |
20070276313 | Moorehead et al. | Nov 2007 | A1 |
20080108956 | Lynn et al. | May 2008 | A1 |
20090292252 | Lareau et al. | Nov 2009 | A1 |
Number | Date | Country |
---|---|---|
20208420 | Oct 2002 | DE |
0128625 | Dec 1984 | EP |
0337617 | Oct 1989 | EP |
0864336 | Sep 1998 | EP |
0930082 | Jul 1999 | EP |
1016431 | Jul 2000 | EP |
2508008 | Dec 1982 | FR |
2718969 | Oct 1995 | FR |
966137 | Aug 1964 | GB |
2102398 | Feb 1983 | GB |
59133877 | Aug 1984 | JP |
63255057 | Oct 1988 | JP |
9038197 | Feb 1997 | JP |
WO-8902764 | Apr 1989 | WO |
WO-9112838 | Sep 1991 | WO |
WO-9206732 | Apr 1992 | WO |
WO-9516480 | Jun 1995 | WO |
WO-9617190 | Jun 1996 | WO |
WO-9623158 | Aug 1996 | WO |
96 40359 | Dec 1996 | WO |
WO-9641649 | Dec 1996 | WO |
WO-9723255 | Jul 1997 | WO |
WO-9726931 | Jul 1997 | WO |
WO-9822178 | May 1998 | WO |
WO-9942166 | Aug 1999 | WO |
WO-0006230 | Feb 2000 | WO |
WO-0044419 | Aug 2000 | WO |
WO-0174434 | Oct 2001 | WO |
WO-03084832 | Oct 2003 | WO |
WO-2005023355 | Mar 2005 | WO |
WO-2008089985 | Jul 2008 | WO |
Entry |
---|
Asch, “Venous access: options, approaches and issues,” Can Assoc. Radiol J., vol. 52, No. 3 pp. 153-164 (2001). |
Herts et al., “Power injection of contrast media using central venous catheters: feasibility, safety, and efficacy,” AJR Am. J. Roentgenol., vol. 176, No. 2, pp. 447-453 (2001). |
Roth et al., “Influence of radiographic contrast media viscosity to flow through coronary angiographic catheters,” Cathet. Cardiovasc. Diagn., vol. 22, No. 4, pp. 290-294 (1991). |
Carlson et al., “Safety considerations in the power injection of contrast media via central venous catheters during computered tomogrphic examinations,” Invest. Radiol., vol. 27, No. 5, p. 337-340 (1992). |
Kaste et al., “Safe use of powr injectors with central and peripheral venous access devices for pediatrict CT,” Pediatr. Radiol., vol. 26, No. 8, pp. 449-501 (1996). |
Herts et al., “Power injection of intravenous contrast material through central venous catheters for CT: in vitro evaluation,” Radiology, vol. 200, No. 3, pp. 731-735 (1996). |
Rivitz et al., “Power injection of peripherally inserted central catheters,” J. Vasc. Interv. Radiol., vol. 8, No. 5, pp. 857-863 (1997). |
Rogalla et al., Safe and easy power injection of contrast material through a central line, Eur. Radiol., vol. 8, No. 1, pp. 148-149 (1998). |
Williamson et al., “Assessing the adequacy of peripherally inserted central catheters for power injection of intravenous contrast agents for CT,” J. Comput. Assist. Tomogr., vol. 25, No. 6, pp. 932-937 (2001). |
Chahous et al., “Randomized comparison of coronary angiography using 4F catheters: 4F manual versus ‘Acisted’ power injection technique,” Catheter Cardiovasc. Interv., vol. 53, No. 2, pp. 221-224 (2001). |
Walsh et al., “Effect of contrast agent viscosity and injection flow velocity on bolus injection pressures for peripheral venous injection in first-pass myocardial perfusion studies,” Technol. Health Care, vol. 10, No. 1, pp. 57-63 (2002). |
Saito et al., “Diagnostic brachial coronary arteriography using a power-assisted injector and 4 French catheters with new shamps,” J. Invasive Cardiol., vol. 9, No. 7, pp. 461-468 (1997). |
International Search Report and Written Opinion mailed Mar. 13, 2007 for International Application No. PCT/US2006/045018 (9 pages). |
International Preliminary Report on Patentability mailed Jul. 29, 2008 for International Application No. PCT/US2006/045018 (7 pages). |
Number | Date | Country | |
---|---|---|---|
20070173777 A1 | Jul 2007 | US |